Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:MJN

Mead Johnson Nutrition (MJN) Stock Price, News & Analysis

Mead Johnson Nutrition logo

About Mead Johnson Nutrition Stock (NYSE:MJN)

Advanced Chart

Key Stats

Today's Range
$89.98
$89.98
50-Day Range
N/A
52-Week Range
$69.25
$94.40
Volume
N/A
Average Volume
3.24 million shs
Market Capitalization
N/A
P/E Ratio
24.25
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mead Johnson Nutrition and its competitors with MarketBeat's FREE daily newsletter.

MJN Stock News Headlines

Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.
Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
See More Headlines

MJN Stock Analysis - Frequently Asked Questions

Mead Johnson Nutrition CO (NYSE:MJN) issued its earnings results on Thursday, April, 27th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.79 by $0.01. The firm's revenue for the quarter was down 8.2% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mead Johnson Nutrition investors own include Bristol-Myers Squibb (BMY), NVIDIA (NVDA), Ford Motor (F), Yum! Brands (YUM), Broadcom (BRCM), Caterpillar (CAT) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
4/27/2017
Today
5/06/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Packaged Foods & Meats
Current Symbol
NYSE:MJN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
24.25
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:MJN) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners